[250 Pages Report] The smart pill technologies market is projected to record a CAGR of 21% during the forecast period, up from US$ 627.1 Million in 2020 to reach a valuation of US$ 6176 Million by 2032.
The smart pill technologies market is anticipated to show promising growth prospects during the forecast period, owing to the increased prevalence of gastrointestinal diseases, sedentary lifestyles, and high patient compliance due to minimally invasive techniques.
Attributes
Details
Smart Pill Technologies Market Value (2020)
US$ 627.1 Million
Smart Pill Technologies Market Value (2032)
US$ 6176 Million
CAGR (2022 to 2032)
21%
The growth of the smart pills technologies market is driven by attractive reimbursement scenarios, patient desire for less invasive treatments, technical improvements in endoscopic techniques, and the growing prevalence of colon cancer. Furthermore, the benefits of smart pills technology, such as breakthroughs in endoscopic procedures, focused medicine administration, and simple remote patient monitoring, boost the sale of smart pills technologies.
Some of the key smart pill technologies market trends promoting the demand for smart pill technologies include the introduction of breakthrough technologies such as catheter-less pH monitoring, ingestible sensors, and wireless capsule-based GI monitoring, which will hasten the expansion of the smart pill technologies market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Key Drivers of the Smart Pill Technologies Market Share?
The smart pill technologies market has a broad scope in monitoring and diagnosing diseases. Due to the increased prevalence of gastrointestinal diseases (such as motility disorders, colon cancer, obscure gastrointestinal bleeding, and Crohn's disease), sedentary lifestyle, and high patient compliance due to minimally invasive techniques, the demand for smart pill technologies and global smart pills technology market is expected to grow significantly in the future.
Also, the changing lifestyle-related syndromes and disorders will further boost the smart pill technologies market. Likewise, the increasing disposable income to avail the evolving innovative technologies in the smart pill technologies market will further help in the penetration of the developed as well as developing countries. This will have a great impact on the demand for smart pill technologies.
The rising geriatric population will also act as a driver of the smart pill technologies market since this segment of the population is more prone to IBD, Ulcerative colitis, and Crohn's disease. The World Health Organization (WHO) has estimated that by 2050 the world's geriatric population count will reach around 2 Bn, which will definitely contribute to the rapid growth of the smart pill technologies market.
Chronic therapy monitoring can help in curtailing health care costs as well. To illustrate the smart pill technologies of ambulatory monitoring with the anti-thrombolytic drug can reduce the number of physicians visits and ensure that anti-thrombolytic therapy is adjusted remotely while ensuring compliance. Thus, supporting the smart pill technologies market and increasing the demand for smart pill technologies.
Which is the Leading Region in the Smart Pill Technologies Market?
The global smart pill technologies market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America and Europe collectively accounted for the largest market share in the overall smart pill technologies market.
North America accounted for about half the share of smart pill technologies market revenue in 2019. The growth in this region is primarily attributed to the increased demand for smart pill technologies, the adoption of novel technologies, a large patient population, high disposable incomes, and the fresh marketing and commercializing of smart pill products. Asia Pacific is expected to grow at a remarkable CAGR for the smart pills technologies market due to increasing healthcare awareness.
Find your sweet spots for generating winning opportunities in this market.
Who are the Key Players in the Smart Pill Technologies Market?
Key players in the global smart pill technologies market include CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, and Bio-Images Research Limited, IntroMedic Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc., Novartis AG, and Philips Healthcare.
Recent Developments
The U.S. Food and Drug Administration authorized Abilify MyCite, aripiprazole tablets with an ingestible sensor from Otsuka Pharmaceuticals and Proteus Digital Health, in November 2017 for the treatment of schizophrenia and other bipolar disorders.
Proteus Digital Health introduced its first digital cancer chemotherapy tablet to the smart pill technologies market with the goal of assisting clinicians in tracking treatment success and adherence in cancer patients.
CapsoCloud, a management system that allowed clinicians to retrieve data from the CapsoCam Plus smart pill without the need to analyze capsules post-ingestion, was launched in the United States by CapsoVision Inc.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Scope Of Report
Report Attribute
Details
Growth rate
CAGR of 21% from 2022 to 2032
Base year for estimation
2021
Historical data
2015 to 2020
Forecast period
2022 to 2032
Quantitative units
Revenue in USD million, volume in kilotons, and CAGR from 2022 to 2032
Report coverage
Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered
Application, Target Area, region
Regional scope
North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope
USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled
CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, and Bio-Images Research Limited, IntroMedic Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc., Novartis AG, and Philips Healthcare.
Customization scope
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs.
Key Segments
By Application:
Patient Monitoring
Drug Delivery
Capsule Endoscopy
By Target Area:
Large Intestine
Small Intestine
Stomach
Esophagus
By Region:
North America
Latin America
Asia Pacific
MEA
Europe
Frequently Asked Questions
What is the Growth Outlook for the Smart Pill Technologies Market?
The smart pill technologies market is likely to register a two-digit CAGR of 21% during the forecast period.
Who are the Key Players in the Smart Pill Technologies Market?
Key players holding substantial smart pill technologies market share include CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, and Bio-Images Research Limited, IntroMedic Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc., Novartis AG, and Philips Healthcare.
What is the Future of the Smart Pill Technologies Market?
As per the analysis, the smart pill technologies market share is likely to be US$ 6176 Mn by 2032.
Which is the Key Driver in the Smart Pill Technologies Market?
Demand for smart pill technologies is likely to be driven by factors such as attractive reimbursement scenarios, patient desire for less invasive treatments, technical improvements in endoscopic techniques, and the growing prevalence of colon cancer.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
5.3.1. Patient Monitoring Technology
5.3.2. Drug Delivery Technology
5.3.3. Capsule Endoscopy Technology
5.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021
5.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
6.3.1. Drug Delivery
6.3.2. Vital Sign Monitoring
6.3.3. Targeted Drug Delivery
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Disease Indication, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032
7.3.1. Small Bowel Tumors
7.3.2. Occult GI Bleeding
7.3.3. Crohn’s Disease
7.3.4. Celiac Disease
7.3.5. Inherited Polyposis Syndromes
7.3.6. Others
7.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017-2021
7.5. Absolute $ Opportunity Analysis By Disease Indication, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Target Area
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By Target Area, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Target Area, 2022-2032
8.3.1. Esophagus
8.3.2. Stomach
8.3.3. Small Intestine
8.3.4. Large Intestine
8.4. Y-o-Y Growth Trend Analysis By Target Area, 2017-2021
8.5. Absolute $ Opportunity Analysis By Target Area, 2022-2032
Deep-dive segmentation will be available in the sample on request
9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
9.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Academic & Research Institutes
9.3.4. Home Care Settings
9.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
9.5. Absolute $ Opportunity Analysis By End User, 2022-2032
Deep-dive segmentation will be available in the sample on request
10. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
10.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia & Pacific
10.3.6. MEA
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. U.K.
11.2.1.2. Canada
11.2.2. By Technology
11.2.3. By Application
11.2.4. By Disease Indication
11.2.5. By Target Area
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Technology
11.3.3. By Application
11.3.4. By Disease Indication
11.3.5. By Target Area
11.3.6. By End User
11.4. Key Takeaways
12. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Technology
12.2.3. By Application
12.2.4. By Disease Indication
12.2.5. By Target Area
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Technology
12.3.3. By Application
12.3.4. By Disease Indication
12.3.5. By Target Area
12.3.6. By End User
12.4. Key Takeaways
13. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. U.K.
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Europe
13.2.2. By Technology
13.2.3. By Application
13.2.4. By Disease Indication
13.2.5. By Target Area
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Technology
13.3.3. By Application
13.3.4. By Disease Indication
13.3.5. By Target Area
13.3.6. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Technology
14.2.3. By Application
14.2.4. By Disease Indication
14.2.5. By Target Area
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Technology
14.3.3. By Application
14.3.4. By Disease Indication
14.3.5. By Target Area
14.3.6. By End User
14.4. Key Takeaways
15. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Thailand
15.2.1.3. Indonesia
15.2.1.4. Malaysia
15.2.1.5. Singapore
15.2.1.6. Australia
15.2.1.7. New Zealand
15.2.1.8. Rest of South Asia & Pacific
15.2.2. By Technology
15.2.3. By Application
15.2.4. By Disease Indication
15.2.5. By Target Area
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Technology
15.3.3. By Application
15.3.4. By Disease Indication
15.3.5. By Target Area
15.3.6. By End User
15.4. Key Takeaways
16. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Technology
16.2.3. By Application
16.2.4. By Disease Indication
16.2.5. By Target Area
16.2.6. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Technology
16.3.3. By Application
16.3.4. By Disease Indication
16.3.5. By Target Area
16.3.6. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. U.K.
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2021
17.1.2.1. By Technology
17.1.2.2. By Application
17.1.2.3. By Disease Indication
17.1.2.4. By Target Area
17.1.2.5. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2021
17.2.2.1. By Technology
17.2.2.2. By Application
17.2.2.3. By Disease Indication
17.2.2.4. By Target Area
17.2.2.5. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2021
17.3.2.1. By Technology
17.3.2.2. By Application
17.3.2.3. By Disease Indication
17.3.2.4. By Target Area
17.3.2.5. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2021
17.4.2.1. By Technology
17.4.2.2. By Application
17.4.2.3. By Disease Indication
17.4.2.4. By Target Area
17.4.2.5. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2021
17.5.2.1. By Technology
17.5.2.2. By Application
17.5.2.3. By Disease Indication
17.5.2.4. By Target Area
17.5.2.5. By End User
17.6. U.K.
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2021
17.6.2.1. By Technology
17.6.2.2. By Application
17.6.2.3. By Disease Indication
17.6.2.4. By Target Area
17.6.2.5. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2021
17.7.2.1. By Technology
17.7.2.2. By Application
17.7.2.3. By Disease Indication
17.7.2.4. By Target Area
17.7.2.5. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2021
17.8.2.1. By Technology
17.8.2.2. By Application
17.8.2.3. By Disease Indication
17.8.2.4. By Target Area
17.8.2.5. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2021
17.9.2.1. By Technology
17.9.2.2. By Application
17.9.2.3. By Disease Indication
17.9.2.4. By Target Area
17.9.2.5. By End User
17.10. China
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2021
17.10.2.1. By Technology
17.10.2.2. By Application
17.10.2.3. By Disease Indication
17.10.2.4. By Target Area
17.10.2.5. By End User
17.11. Japan
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2021
17.11.2.1. By Technology
17.11.2.2. By Application
17.11.2.3. By Disease Indication
17.11.2.4. By Target Area
17.11.2.5. By End User
17.12. South Korea
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2021
17.12.2.1. By Technology
17.12.2.2. By Application
17.12.2.3. By Disease Indication
17.12.2.4. By Target Area
17.12.2.5. By End User
17.13. India
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2021
17.13.2.1. By Technology
17.13.2.2. By Application
17.13.2.3. By Disease Indication
17.13.2.4. By Target Area
17.13.2.5. By End User
17.14. Thailand
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2021
17.14.2.1. By Technology
17.14.2.2. By Application
17.14.2.3. By Disease Indication
17.14.2.4. By Target Area
17.14.2.5. By End User
17.15. Indonesia
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2021
17.15.2.1. By Technology
17.15.2.2. By Application
17.15.2.3. By Disease Indication
17.15.2.4. By Target Area
17.15.2.5. By End User
17.16. Malaysia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2021
17.16.2.1. By Technology
17.16.2.2. By Application
17.16.2.3. By Disease Indication
17.16.2.4. By Target Area
17.16.2.5. By End User
17.17. Singapore
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2021
17.17.2.1. By Technology
17.17.2.2. By Application
17.17.2.3. By Disease Indication
17.17.2.4. By Target Area
17.17.2.5. By End User
17.18. Australia
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2021
17.18.2.1. By Technology
17.18.2.2. By Application
17.18.2.3. By Disease Indication
17.18.2.4. By Target Area
17.18.2.5. By End User
17.19. New Zealand
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2021
17.19.2.1. By Technology
17.19.2.2. By Application
17.19.2.3. By Disease Indication
17.19.2.4. By Target Area
17.19.2.5. By End User
17.20. GCC Countries
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2021
17.20.2.1. By Technology
17.20.2.2. By Application
17.20.2.3. By Disease Indication
17.20.2.4. By Target Area
17.20.2.5. By End User
17.21. South Africa
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2021
17.21.2.1. By Technology
17.21.2.2. By Application
17.21.2.3. By Disease Indication
17.21.2.4. By Target Area
17.21.2.5. By End User
17.22. Israel
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2021
17.22.2.1. By Technology
17.22.2.2. By Application
17.22.2.3. By Disease Indication
17.22.2.4. By Target Area
17.22.2.5. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Technology
18.3.3. By Application
18.3.4. By Disease Indication
18.3.5. By Target Area
18.3.6. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Boston Scientific Corporation
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. GE Healthcare
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Microchips
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Novartis AG
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Olympus Medical Technology
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Phillips
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Otsuka America Pharmaceutical, Inc
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Yooma Wellness Inc.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Medtronic Private Limited
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. CapsoVision, Inc.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 3: Global Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 4: Global Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032
Table 5: Global Market Value (US$ Mn) Forecast by Target Area, 2017-2032
Table 6: Global Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 7: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: North America Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 9: North America Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 10: North America Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032
Table 11: North America Market Value (US$ Mn) Forecast by Target Area, 2017-2032
Table 12: North America Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 13: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Latin America Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 15: Latin America Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 16: Latin America Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032
Table 17: Latin America Market Value (US$ Mn) Forecast by Target Area, 2017-2032
Table 18: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 19: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Europe Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 21: Europe Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 22: Europe Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032
Table 23: Europe Market Value (US$ Mn) Forecast by Target Area, 2017-2032
Table 24: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 25: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: East Asia Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 27: East Asia Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 28: East Asia Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032
Table 29: East Asia Market Value (US$ Mn) Forecast by Target Area, 2017-2032
Table 30: East Asia Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 31: South Asia & Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 32: South Asia & Pacific Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 33: South Asia & Pacific Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 34: South Asia & Pacific Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032
Table 35: South Asia & Pacific Market Value (US$ Mn) Forecast by Target Area, 2017-2032
Table 36: South Asia & Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 37: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 38: MEA Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 39: MEA Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 40: MEA Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032
Table 41: MEA Market Value (US$ Mn) Forecast by Target Area, 2017-2032
Table 42: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Mn) by Technology, 2022-2032
Figure 2: Global Market Value (US$ Mn) by Application, 2022-2032
Figure 3: Global Market Value (US$ Mn) by Disease Indication, 2022-2032
Figure 4: Global Market Value (US$ Mn) by Target Area, 2022-2032
Figure 5: Global Market Value (US$ Mn) by End User, 2022-2032
Figure 6: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 7: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 10: Global Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 11: Global Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 13: Global Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 14: Global Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 15: Global Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 16: Global Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032
Figure 17: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032
Figure 18: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032
Figure 19: Global Market Value (US$ Mn) Analysis by Target Area, 2017-2032
Figure 20: Global Market Value Share (%) and BPS Analysis by Target Area, 2022-2032
Figure 21: Global Market Y-o-Y Growth (%) Projections by Target Area, 2022-2032
Figure 22: Global Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 23: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 24: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 25: Global Market Attractiveness by Technology, 2022-2032
Figure 26: Global Market Attractiveness by Application, 2022-2032
Figure 27: Global Market Attractiveness by Disease Indication, 2022-2032
Figure 28: Global Market Attractiveness by Target Area, 2022-2032
Figure 29: Global Market Attractiveness by End User, 2022-2032
Figure 30: Global Market Attractiveness by Region, 2022-2032
Figure 31: North America Market Value (US$ Mn) by Technology, 2022-2032
Figure 32: North America Market Value (US$ Mn) by Application, 2022-2032
Figure 33: North America Market Value (US$ Mn) by Disease Indication, 2022-2032
Figure 34: North America Market Value (US$ Mn) by Target Area, 2022-2032
Figure 35: North America Market Value (US$ Mn) by End User, 2022-2032
Figure 36: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 37: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 40: North America Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 43: North America Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 44: North America Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 46: North America Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032
Figure 47: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032
Figure 48: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032
Figure 49: North America Market Value (US$ Mn) Analysis by Target Area, 2017-2032
Figure 50: North America Market Value Share (%) and BPS Analysis by Target Area, 2022-2032
Figure 51: North America Market Y-o-Y Growth (%) Projections by Target Area, 2022-2032
Figure 52: North America Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 53: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 54: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 55: North America Market Attractiveness by Technology, 2022-2032
Figure 56: North America Market Attractiveness by Application, 2022-2032
Figure 57: North America Market Attractiveness by Disease Indication, 2022-2032
Figure 58: North America Market Attractiveness by Target Area, 2022-2032
Figure 59: North America Market Attractiveness by End User, 2022-2032
Figure 60: North America Market Attractiveness by Country, 2022-2032
Figure 61: Latin America Market Value (US$ Mn) by Technology, 2022-2032
Figure 62: Latin America Market Value (US$ Mn) by Application, 2022-2032
Figure 63: Latin America Market Value (US$ Mn) by Disease Indication, 2022-2032
Figure 64: Latin America Market Value (US$ Mn) by Target Area, 2022-2032
Figure 65: Latin America Market Value (US$ Mn) by End User, 2022-2032
Figure 66: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 67: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 70: Latin America Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 71: Latin America Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 72: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 73: Latin America Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 74: Latin America Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 75: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 76: Latin America Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032
Figure 77: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032
Figure 78: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032
Figure 79: Latin America Market Value (US$ Mn) Analysis by Target Area, 2017-2032
Figure 80: Latin America Market Value Share (%) and BPS Analysis by Target Area, 2022-2032
Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Target Area, 2022-2032
Figure 82: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 83: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 84: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 85: Latin America Market Attractiveness by Technology, 2022-2032
Figure 86: Latin America Market Attractiveness by Application, 2022-2032
Figure 87: Latin America Market Attractiveness by Disease Indication, 2022-2032
Figure 88: Latin America Market Attractiveness by Target Area, 2022-2032
Figure 89: Latin America Market Attractiveness by End User, 2022-2032
Figure 90: Latin America Market Attractiveness by Country, 2022-2032
Figure 91: Europe Market Value (US$ Mn) by Technology, 2022-2032
Figure 92: Europe Market Value (US$ Mn) by Application, 2022-2032
Figure 93: Europe Market Value (US$ Mn) by Disease Indication, 2022-2032
Figure 94: Europe Market Value (US$ Mn) by Target Area, 2022-2032
Figure 95: Europe Market Value (US$ Mn) by End User, 2022-2032
Figure 96: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 97: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 98: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 99: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 100: Europe Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 101: Europe Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 102: Europe Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 103: Europe Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 104: Europe Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 105: Europe Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 106: Europe Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032
Figure 107: Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032
Figure 108: Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032
Figure 109: Europe Market Value (US$ Mn) Analysis by Target Area, 2017-2032
Figure 110: Europe Market Value Share (%) and BPS Analysis by Target Area, 2022-2032
Figure 111: Europe Market Y-o-Y Growth (%) Projections by Target Area, 2022-2032
Figure 112: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 113: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 114: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 115: Europe Market Attractiveness by Technology, 2022-2032
Figure 116: Europe Market Attractiveness by Application, 2022-2032
Figure 117: Europe Market Attractiveness by Disease Indication, 2022-2032
Figure 118: Europe Market Attractiveness by Target Area, 2022-2032
Figure 119: Europe Market Attractiveness by End User, 2022-2032
Figure 120: Europe Market Attractiveness by Country, 2022-2032
Figure 121: East Asia Market Value (US$ Mn) by Technology, 2022-2032
Figure 122: East Asia Market Value (US$ Mn) by Application, 2022-2032
Figure 123: East Asia Market Value (US$ Mn) by Disease Indication, 2022-2032
Figure 124: East Asia Market Value (US$ Mn) by Target Area, 2022-2032
Figure 125: East Asia Market Value (US$ Mn) by End User, 2022-2032
Figure 126: East Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 127: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 128: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 129: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 130: East Asia Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 131: East Asia Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 132: East Asia Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 133: East Asia Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 134: East Asia Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 135: East Asia Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 136: East Asia Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032
Figure 137: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032
Figure 138: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032
Figure 139: East Asia Market Value (US$ Mn) Analysis by Target Area, 2017-2032
Figure 140: East Asia Market Value Share (%) and BPS Analysis by Target Area, 2022-2032
Figure 141: East Asia Market Y-o-Y Growth (%) Projections by Target Area, 2022-2032
Figure 142: East Asia Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 143: East Asia Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 144: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 145: East Asia Market Attractiveness by Technology, 2022-2032
Figure 146: East Asia Market Attractiveness by Application, 2022-2032
Figure 147: East Asia Market Attractiveness by Disease Indication, 2022-2032
Figure 148: East Asia Market Attractiveness by Target Area, 2022-2032
Figure 149: East Asia Market Attractiveness by End User, 2022-2032
Figure 150: East Asia Market Attractiveness by Country, 2022-2032
Figure 151: South Asia & Pacific Market Value (US$ Mn) by Technology, 2022-2032
Figure 152: South Asia & Pacific Market Value (US$ Mn) by Application, 2022-2032
Figure 153: South Asia & Pacific Market Value (US$ Mn) by Disease Indication, 2022-2032
Figure 154: South Asia & Pacific Market Value (US$ Mn) by Target Area, 2022-2032
Figure 155: South Asia & Pacific Market Value (US$ Mn) by End User, 2022-2032
Figure 156: South Asia & Pacific Market Value (US$ Mn) by Country, 2022-2032
Figure 157: South Asia & Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 158: South Asia & Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 159: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 160: South Asia & Pacific Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 161: South Asia & Pacific Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 162: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 163: South Asia & Pacific Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 164: South Asia & Pacific Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 165: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 166: South Asia & Pacific Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032
Figure 167: South Asia & Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032
Figure 168: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032
Figure 169: South Asia & Pacific Market Value (US$ Mn) Analysis by Target Area, 2017-2032
Figure 170: South Asia & Pacific Market Value Share (%) and BPS Analysis by Target Area, 2022-2032
Figure 171: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Target Area, 2022-2032
Figure 172: South Asia & Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 173: South Asia & Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 174: South Asia & Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 175: South Asia & Pacific Market Attractiveness by Technology, 2022-2032
Figure 176: South Asia & Pacific Market Attractiveness by Application, 2022-2032
Figure 177: South Asia & Pacific Market Attractiveness by Disease Indication, 2022-2032
Figure 178: South Asia & Pacific Market Attractiveness by Target Area, 2022-2032
Figure 179: South Asia & Pacific Market Attractiveness by End User, 2022-2032
Figure 180: South Asia & Pacific Market Attractiveness by Country, 2022-2032
Figure 181: MEA Market Value (US$ Mn) by Technology, 2022-2032
Figure 182: MEA Market Value (US$ Mn) by Application, 2022-2032
Figure 183: MEA Market Value (US$ Mn) by Disease Indication, 2022-2032
Figure 184: MEA Market Value (US$ Mn) by Target Area, 2022-2032
Figure 185: MEA Market Value (US$ Mn) by End User, 2022-2032
Figure 186: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 187: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 188: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 189: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 190: MEA Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 191: MEA Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 192: MEA Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 193: MEA Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 194: MEA Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 195: MEA Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 196: MEA Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032
Figure 197: MEA Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032
Figure 198: MEA Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032
Figure 199: MEA Market Value (US$ Mn) Analysis by Target Area, 2017-2032
Figure 200: MEA Market Value Share (%) and BPS Analysis by Target Area, 2022-2032
Figure 201: MEA Market Y-o-Y Growth (%) Projections by Target Area, 2022-2032
Figure 202: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 203: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 204: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 205: MEA Market Attractiveness by Technology, 2022-2032
Figure 206: MEA Market Attractiveness by Application, 2022-2032
Figure 207: MEA Market Attractiveness by Disease Indication, 2022-2032
Figure 208: MEA Market Attractiveness by Target Area, 2022-2032
Figure 209: MEA Market Attractiveness by End User, 2022-2032
Figure 210: MEA Market Attractiveness by Country, 2022-2032
